ContextVision launches New Products and Upgrades at RSNA 2017

At this year’s Annual Meeting of RSNA, the Radiological Society of North America (starting today), ContextVision launches a new product for ultrasound and an upgrade of the latest product for x-ray. The new group of products for ultrasound, VolarView™, serves the needs of handheld ultrasound which is increasingly being used in the fast-growing point of […]

ContextVision broadens Digital Pathology Advisory Board

STOCKHOLM – November 8, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has added new members to its advisory board for DESUTO, a Eurostar sponsored research program within digital pathology. Professor Junya Fukuoka of the Department of Pathology in Nagasaki and Professor Fredrik Pontén of Uppsala University have both […]

ContextVision AB: “The Leader of the Year 2017” – finalist

Stockholm, Sweden – November 6th, 2017 – Anita Tollstadius, CEO of ContextVision, is one of five finalists among CEOs for small companies in Sweden, an award founded by management website motivation.se. There were in total 120 nominations in four different categories, and the winner will be announced on November 16th. Being one of the finalists […]

ContextVision AB presents Q3 2017 Financial report

ContextVision establishes unique platform for future growth within digital pathology   STOCKHOLM – October 26, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has heavily invested in developing state-of-the-art competence within artificial intelligence and the development of a first product within digital pathology that will make the diagnosis of […]

ContextVision AB invitation to company presentation

INVITATION    We are pleased to invite you to a presentation of Contextvision AB and its first half year 2017 figures at the offices of Norne Securities AS (Oslo Office), Haakon VIIs gt. 9, Oslo;     Wednesday, September13th at 12.00 Lunch will be served     We are very happy that ContextVision developed well […]

ContextVision AB Secures Patent Approval for Artificial Intelligence Technology

STOCKHOLM – August 31st, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, received a US patent approval for a new technology based on artificial intelligence. The technology serves to optimize image quality within ultrasound as well as other medical modalities i.e. MRI, X-ray and CT. The patent was filed […]

ContextVision AB Q2 Financial Report

 ContextVision Sees Highest Q2 Sales STOCKHOLM – Aug. 17, 2017 –  ContextVision reached record-breaking sales in the second quarter 2017. Total sales reached 22,7 MSEK, 24 percent higher than second quarter last year. The progress within digital pathology is on track and a collaboration was initiated with a world-class research team in Uppsala.  ContextVision, a world-leading […]

ContextVision board member share purchase

Stockholm, Sweden – May 24, 2017 –  Karin Bernadotte, member of the board of ContextVision AB, has purchased 2 000 shares in ContextVision AB. On May 23rd 2017 Karin Bernadotte purchased 2 000 shares at an average price of NOK 58,00. Following this transaction Karin Bernadotte owns 8 500 shares in ContextVision AB. “ContextVision has started to develop […]